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Purposes: To identify the socio-demographic and anthropometric proﬁle and correlate them
with  the severity of menopausal symptoms in postmenopausal women.
Methods: Cross-sectional study with 201 postmenopausal women attended in a Gyne-
cology Outpatient Department in Rio de Janeiro city (RJ, Brazil). A questionnaire was
applied for collection of demographic, socioeconomic, clinical and lifestyle variables. The
Blatt–Kupperman Menopausal Index was used to evaluate the menopausal symptoms.
Results: Women with moderate to severe symptoms (≥20) corresponded to 57.7% (116) of the
sample. Obesity was not associated with the severity of menopausal symptoms (p < 0.90).
Severe to moderate symptoms were inversely associated with age (PR 0.96; CI 95% 0.94–0.99;
p  < 0.01). Women within 6–10 years of menopause presented nearly 1.4 times higher preva-
lence  of moderate to severe symptoms compared with those with more than 10 years of
menopause. Unemployed women (PR 1.52; CI 95% 1.13–2.04; p < 0.01) and housewives (PR
1.53; CI 95% 1.12–2.09; p < 0.01) presented higher prevalence of menopausal symptoms com-
pared with working women. Tobaccoism was associated with higher prevalence of moderate
to  severe symptoms (p < 0.01).
Conclusions: Age constituted a protection factor for moderate to severe symptoms, whereas
having within 6–10 years of menopause, smoking and being unemployed or a housewife
were factors related to higher prevalence of moderate to severe menopausal symptoms.
©  2015 Sociedade Brasileira de Reproduc¸ão Humana. Published by Elsevier Editora Ltda.
All rights reserved.
Fatores  associados  com  a  intensidade  dos  sintomas  menopausais
em  mulheres  brasileiras  na  pós-menopausa
r  e  s  u  m  oPalavras-chave:
Intensidade dos sintomas
menopausais
Objetivo: Identiﬁcar o perﬁl sociodemográﬁco e antropométrico e associá-los com a intensi-
dade dos sintomas menopausais em mulheres na pós-menopausa.
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Pós-menopausa
Fatores de risco
Sinais e sintomas
Sintomas menopausais
Métodos: Estudo transversal com 201 mulheres na pós-menopausa atendidas em um ambu-
latório de ginecologia no Rio de Janeiro/RJ. Foi aplicado um questionário para coleta das
variáveis demográﬁcas, socioeconômicas, clínicas e hábitos de vida. O Índice Menopausal
de  Blatt–Kupperman (IMBK) foi utilizado para avaliar os sintomas menopausais.
Resultados: Mulheres com sintomas moderados a grave (≥20) corresponderam a 57,7% (116)
da  amostra. A obesidade não foi associada com a intensidade de sintomas menopausais
(p  < 0,90). Os sintomas moderados a intensos associaram-se inversamente com a idade (RP
0,96; IC95% 0,94–0,99; p < 0,01). Mulheres com tempo de menopausa entre 6 e 10 anos apre-
sentaram cerca de 1,4 vezes maior prevalência de sintomas moderados a intensos quando
comparadas com aquelas com mais de 10 anos de menopausa. Mulheres desempregadas
(RP  1,52; IC95% 1,13–2,04; p < 0,01) e donas de casa (RP 1,53; IC95% 1,12–2,09; p < 0,01) apre-
sentaram maior prevalência de sintomas menopausais quando comparadas com mulheres
trabalhando. O tabagismo foi associado a maior prevalência de sintomas moderados a inten-
sos  (p < 0,01).
Conclusões: A idade constituiu fator de protec¸ão para sintomas moderados a intensos.
Enquanto que ter entre 6 à 10 anos de tempo de menopausa, ser tabagista e ser desem-
pregada ou dona de casa foram fatores associados a uma maior prevalência de sintomas
menopausais moderados a intensos.
© 2015 Sociedade Brasileira de Reproduc¸ão Humana. Publicado por Elsevier Editora
Ltda. Todos os direitos reservados.
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enopause is an event that marks the end of the reproductive
hase of a woman. This condition is caused by the reduction
f the ovarian function, with gradual decrease of female sex-
al hormones leading to menstrual cycle interruption. The
eriod after the deﬁnite interruption of menstruation, in other
ords, after the absence of menstrual cycles for twelve con-
ecutive months is characterized by post-menopause.1 This
eriod, for times, is accompanied by vasomotor, psychological
nd urogenital symptoms, besides metabolic and cardiovascu-
ar alterations, like osteoporosis, cardiovascular diseases and
lterations in the distribution of physical fat.2–4
In Brazil, changes in morbidity and mortality patterns from
nfectious diseases to chronic non-communicable diseases,
long with life expectancy increase, have brought an impor-
ant impact to questions related to female aging.5 Nearly 28%
f women (24.3 million) are aged 40 years and older in Brazil
nd, in the city of Rio de Janeiro the female population esti-
ate of 2010 was 3.09 million women, of which 34.1% were
n the age group 40–64 years.6 Menopause typically occurs
etween 45 and 55 years of age, and woman life expectancy is
round 70 years. Therefore, the post-menopause period cor-
esponds to around 1/3 of a woman’s lifespan.7
The severity of menopausal symptoms compromise daily
ife activities and social life; thus, impairing quality of life and
egatively impacting on public health.8 Menopausal symp-
oms may vary in frequency and severity.9 Therefore some
tudies have investigated factors that can be associated with
he severity of these symptoms, such as age8,10 menopausal
tage,11–13 socioeconomic aspects,8,12 lifestyle,8,12,14,15 chronic
onditions and comorbities12,14,16–18; but some ﬁndings are
onﬂicting between studies.Due to the conﬂicting evidences in the literature, fur-
her studies that investigate possible predictor factors to
he severity of menopausal symptoms in postmenopausalwomen are necessary. This information is important so that
health professionals can intervene more  appropriately and
speciﬁcally.19 Thus, the objective of the present study was
to identify the socio-demographic and anthropometric proﬁle
and associate it with the severity of menopausal symptoms in
postmenopausal women attended in the Gynecology Outpa-
tient Department (Oswaldo Cruz Foundation, FIOCRUZ, Rio de
Janeiro, RJ, Brazil).
Methods
This is a cross-sectional study. The study was approved by
the Research Ethics Committee of the National Institute of
Women, Children and Adolescents Health Fernandes Figueira
(IFF), Oswaldo Cruz Foundation (FIOCRUZ, RJ, Brazil) and per-
formed in a reference Gynecology Outpatient Department in
Rio de Janeiro city. The data collection period was August
to December/2013. The study population was constituted
by postmenopausal women attended by the subspecial-
ties of urogynecology, general gynecology and reproductive
endocrinology in the above-mentioned outpatient depart-
ment.
Women aged between 45 and 65 years and without
menstrual periods for 12 consecutive months or more  (post-
menopausal period) were included in the study. Women who
were taking hormone replacement therapy (HRT) or had inter-
rupted this treatment for less than 12 months, submitted
to chemotherapy or radiotherapy due to cancer, to bilateral
oophorectomy or presented decompensated hypothyroidism
and/or Cushing’s disease, or clinical history of premature
menopause, i.e. menstrual cycle interruption earlier than
40 years of age17 were excluded from the study. Lab-
oratorial tests (Thyroid-Stimulating Hormone, TSH; Free
Thyroxine, free T4 and Follicle-Stimulating Hormone, FSH)
were requested for all study participants, for eligibility pur-
poses. Decompensated hypothyroidism was characterized
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when TSH and free T4 test results were outside of the refer-
ence values (9–20 pmol/L for free T4 and 0.25–5 mcgUl/mL for
TSH), using enzyme-linked ﬂuorescence assay (ELFA, VIDAS®
commercial kit, Biomérieux AS, Brazil). Women who presented
FSH ≤40 mUI/mL were excluded from the study, as recom-
mended by the Ministry of Health.5 Tests were performed at
the IFF/FIOCRUZ laboratory. All results were transferred to the
patients’ records.
All women in the waiting room with booked appointments
to the studied subspecialties and who were eligible for the
study were invited to participate in the study. After accep-
tance in the study, the women were directed to an individual
room, local service where they were handed the Informed
Consent form, in accordance with Resolution 466/2012 of the
National Council of Health (Ministry of Health, Brazil), so
that participants could show their agreement as for the par-
ticipation in the study. In the same place, a closed-ended
questionnaire for collection of demographic, socioeconomic,
clinical and lifestyle variables (named clinical record), and
the Blatt–Kupperman Menopausal Index for evaluation of
menopausal symptoms were applied.
The Blatt–Kupperman Menopausal Index is used to evalu-
ate the severity of symptoms through eleven questions that
include somatic and psychological symptoms. Each symptom
is evaluated as absent (0), mild (1), moderate (2) and severe
(3). For this study, the severity of symptoms was scored as <20
absent to mild and ≥20 moderate to severe.10,14,20,21
As to physical activity, women were classiﬁed as active
(very activate and active) and sedentary (irregularly active A,
irregularly active B and sedentary) according to the Interna-
tional Physical Activity Questionnaire (IPAQ-c).22,23
After ﬁlling out the clinical record, the weight (kg) was
measured in a digital scale (model LD1050, Líder, Brazil), with
INMETRO certiﬁcation (N. 7.217.026-6). The height (cm) was
measured using a wall-mounted stadiometer (Wiso, Brazil)
respecting the Frankfurt plane position.24 The body mass
index (BMI) was calculated using the formula: Weight
Height2
(kg/m2).
Results were classiﬁed as eutrophic (BMI 18.5–24.9), over-
weight (BMI 25.0–29.9) and obese (BMI ≥ 30.0).25
The waist to hip ratio (WHR) was obtained by measuring the
waist circumference (WC) (tape measure positioned at midway
distance between the last ﬂoating rib and the iliac crest)26 and
the hip circumference (HC) (tape measure positioned at the
largest gluteal area).27 WC and HC were double-checked and
the arithmetic mean was registered in the database. The used
cutoff value was ≥0.80 for women, which indicated cardiovas-
cular risk.27
It was veriﬁed that 748 women attended in the outpa-
tient gynecology department in the studied period were aged
45–65 years; 332 women reported having menstrual cycle,
53 were currently taking HRT, 46 reported having done
chemotherapy/radiotherapy due to cancer, 24 had early
menopause, 37 performed bilateral oophorectomy and 40
refused to participate in the study. A total of 216 women were
recruited, and one woman was evaluated more  than once
because she was attended on different days and in different
subspecialties. Twelve women had FSH ≤40 mUl/mL, two did
not show up for the laboratorial tests; consequently, ﬁfteen
women were excluded from the study for ineligibility. 5;3  0(2):70–76
Statistical  analysis
When normality was not veriﬁed, results were expressed as
median, minimum and maximum values. Chi-square test
was used to determine statistical signiﬁcance of associations
between categorical variables. Fisher’s exact test was applied
if at least one expected frequency below ﬁve was observed.
Mann–Whitney test was used to investigate statistically signif-
icant differences between averages. Variables that presented
p-value lower than 0.20 were included in the Poisson regres-
sion model. The statistical signiﬁcance level was 5%. The
software programs used for analysis of data were SPSS, version
20 and R, version 3.0.2.
Results
During the study period, 748 women aged 45–65 years were
attended in the gynecology outpatient department. Of this
total, 28.9% (216) met  the inclusion criteria and 93% (201) of
them participated in the study. More than 57% (116) of women
reported moderate to severe symptoms (≥20).
It was observed that the median age (57.0) of the group
with more  severe symptoms was lower than the median age
of the group with absent or mild symptoms (59.0) (p < 0.01).
Around 2/3 of the women who were within 6–10 years
of menopause (68.5%) reported moderate to severe symp-
toms, whereas less than half of women with more  than 10
years of menopause reported the same severity of symp-
toms (47.8%), Table 1. There was no statistically signiﬁcant
difference between schooling and severity of menopausal
symptoms. The same fact occurred for marital status, and
income.
The prevalence of women with moderate to severe symp-
toms who smoked (79.2%) was higher when compared with
those who were non-smokers (51.9%, p < 0.01, Table 1).
Most women participating in the study were obese (39.8%)
and 56.2% of them reported moderate to severe symptoms.
It was also veriﬁed that more  than 60% of eutrophic women
reported moderate to severe symptoms, presenting no statisti-
cally signiﬁcant difference. High prevalence of cardiovascular
risk was observed, given that more  than 95% of women pre-
sented WHR  ≥0.80 and a little less than 3/5 of them presented
moderate to severe menopausal symptoms (p = 0.15).
The prevalence of different types of moderate to intense
menopausal symptoms is in Table 2. It was found that among
these complaints arthralgia/myalgia was the most reported
symptom among women studied with 62.7% prevalence, fol-
lowed nervousness with 59.7% and hot ﬂashes with 50.7%.
And the least reported symptoms were dizziness (18.9%) and
tinnitus (19.4%).
After the multivariate analysis, it could be observed that
the moderate to severe menopausal symptoms were inversely
associated with age (PR 0.96; CI 95% 0.94–0.99; p < 0.01).
Women who were within 6–10 years of menopause pre-
sented nearly 1.4 times higher prevalence of moderate to
severe symptoms when compared with those with more
than 10 years after menopause (p < 0.03). Unemployed women
(PR 1.52; CI 95% 1.13–2.04; p < 0.01) and housewives (PR 1.53;
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Table 1 – Patient characteristics and prevalence of moderate or severe menopausal symptoms in postmenopausal
women attended in a Gynecology Outpatient Department from August to December/2013 (n = 201).
Variables % n Prevalence of
moderate to severe
symptoms %
n  = 116 p-Value
Agea,b 57.00 [45–65] 57.00 [45–65] <0.01
Marital status 0.67
Single 15.4 31 54.8 17
Divorced 11.9 24 54.2 13
Widow 11.4 23 69.6 16
Married 61.2 123 56.9 70
Schooling yearsa 8.00 [0–17] 0.18
0–5 34.8 70 67.1 47 0.23
6–9a 29.9 60 50 30
10–11a 29.9 60 55 33
12–17 5.5 11 54.5 6
Occupationa <0.01
Unemployeda 13.4 27 81.5 22
Retired 19.9 40 50 20
Housewifea 13.9 28 71.4 20
Working 52.7 106 50.9 54
Per capita income 0.17
0–1 61.8 123 62.6 77
1–2 27.6 55 52.7 29
≥2 10.6 21 42.9 9
BMI 0.90
Eutrophic 22.9 46 60.9 28
Overweight 37.3 75 57.3 43
Obese 39.8 80 56.2 45
WHR ≥ 0.80a 97.0 195 57.9 113 0.15
Pregnanciesa 3.0 [0–21] 3.00 [0–8] 0.02
Menopause timeb 7.00 [1–25] 0.31
1–5 yearsa 39.8 80 58.8 47 0.07
6–10 yearsa 26.9 54 68.5 37
>10 years 33.3 67 47.8 32
Smokinga 0.04
Yesa 11.9 24 79.2 19
No 52.7 106 51.9 55
Ex 35.3 71 59.2 42
Alcohol consumption 0.75
Yes 28.4 57 59.6 34
No 71.6 144 56.9 82
Physical activity 0.25
Active 43.3 87 52.9 46
Sedentary 56.7 114 61.4 70
Source: Study data, 2014.
MS, metabolic syndrome; BMI, body mass index; WHR, waist to hip ratio.
Data are expressed as median [min–max] or percentages %.
a p-Value found in univariate regression analyses was <0.20.
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Tb Mann–Whitney test; Chi-square test was used to check statistical s
I 95% 1.12–2.09; p < 0.01) presented higher prevalence of
enopausal symptoms compared with working women.
nd ﬁnally, the prevalence of women who smoke pre-
enting moderate to severe symptoms was 1.45 times higher
han in non-smokers (PR 1.45; CI 95% 1.10–1.90; p < 0.01),
able 3.cance of associations between categorical variables.
DiscussionIt was veriﬁed that age was a protection factor for moderate
to severe symptoms. In the study of De Lorenzi and col-
laborators, it was noticed that the obtained score decreased
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Table 2 – Prevalence of moderate or severe menopausal
symptoms in postmenopausal women attended in a
Gynecology Outpatient Department from August to
December/2013 (n = 201).
Symptoms Moderate to
severe % (n)
Arthralgias/myalgias 62.7% (126)
Nervousness 59.7% (120)
Hot ﬂushes 50.7% (102)
Insomnia/sleep disturbances 47.3% (95)
Depressive mood/melancholia 30.3% (61)
Paresthesia 30.3% (61)
Weakness (fatigue) 43.3% (87)
Cephalea 27.9% (56)
Palpitations 26.4% (53)
Tinnitus 19.4% (39)
Dizziness 18.9% (38)
Source: Study data, 2014.
Table 3 – Factors associated with moderate to severe
menopausal symptoms (BKMI ≥ 20) in postmenopausal
women attended in a Gynecology Outpatient
Department from August to December/2013. Data were
submitted to multiple regression analysis.a
Variables PR adjusted (CI 95%) p-Valuea
Age 0.9 (0.94–0.99) 0.01
Menopause time
1–5 years 1.1 (0.80–1.54) 0.55
6–10 years 1.4 (1.04–1.89) 0.03
>10 years 1.00 –
Number of pregnancies 1.0 (0.99–1.09) 0.10
Schooling
0–5 years 1.00 –
6–9 years 0.8 (0.58–1.07) 0.12
10–11 years 0.8 (0.66–1.11) 0.24
12–17 years 0.9 (0.51–1.48) 0.60
Occupation
Unemployed 1.5 (1.13–2.04) 0.01
Retired 1.1 (0.78–1.57) 0.56
Housewife 1.5 (1.12–2.09) 0.01
Working 1.00 –
Per capita income
0–1 minimum wage 1.00 –
1–2 minimum wages 1.00 (0.75–1.33) 0.99
≥2 minimum wages 0.9 (0.54–1.52) 0.70
Smoking
Yes 1.6 (1.10–1.90) 0.01
No 1.00 –
Ex 1.1 (0.84–1.40) 0.52
Waist to hip ratio 4.8 (0.87–26.35) 0.07
Source: Study data, 2014.
PR, prevalence ratio; CI 95%, conﬁdence interval at 95%.
a Adjusted for age, menopause time, number of pregnancies,
schooling, occupation, per capita income, tobaccoism and WHR. 5;3  0(2):70–76
as age increased, but signiﬁcant statistical relation was
not demonstrated.8 Differently from this ﬁnding, another
study demonstrated that women aged 60 years and older
had around 0.38 times less chance of presenting moder-
ate to severe climacteric symptoms, reinforcing that older
women reported fewer menopausal symptoms compared with
younger women.10 It is possible to infer that most women
aged 56 years and older at the present study were more  than
10 years past menopause, perhaps explaining the fact that
in this is study younger women reported higher severity of
symptoms.
It was observed that the prevalence of women with mod-
erate to severe symptoms within 6–10 years of menopause
was 1.4 times higher than among those with more  than
10 years past menopause. In another study, signiﬁcant sta-
tistical difference was not observed regarding time after
menopause and moderate to severe symptoms, but there
is methodological difference between data collection of the
studies.14 In a study developed in Brazil, it was noticed that
menopausal symptoms tended to reduce with time after
menopause, except for arthralgia, myalgia and insomnia, per-
haps for being associated with aging.18 In this study it was
found that the arthralgia/myalgia was the most prevalent
complaint among moderate to severe symptoms, which may
be an explanation for the peak of symptoms to be between
6 and 10 years of menopause time. Postmenopause is divided
into early postmenopause and late postmenopause, consider-
ing early postmenopause as the ﬁrst ﬁve years after the onset
of menopause.28 The time of onset of menopause can directly
inﬂuence the severity of menopausal symptoms, since after
some years of menopause, hormonal stability occurs, leading
to reduction or absence of symptoms that previously impaired
quality of life.29
It was also noticed that the prevalence of unemployed
women or housewives with moderate to severe symptoms was
nearly 50% higher than that observed in women who  worked
at the time of the study. Such a fact was not veriﬁed in a study
that aimed at indicating factors associated with menopausal
symptoms.8 A higher prevalence of neuropsychiatric symp-
toms during postmenopause suggests that this ﬁnding can be
explained by the negative perception of aging and feeling of
inutility, which is a difﬁcult condition for women.30 The inter-
pretation of the results that correlate occupation and severity
of menopausal symptoms is difﬁcult in this case, as this is a
cross-sectional design, in which there is possibility of reverse
causality, characterizing a limitation of the present study.
Regarding lifestyle, women who smoke presented higher
prevalence of moderate to severe symptoms, corroborating
previous studies, such as that of Pérez et al., who  veriﬁed
that women  who smoked presented 1.92 more  chances to
report more  severe symptoms compared with women  who  did
not smoke.31 Smoking has been previously associated with
menopausal symptoms.32–34 Studies show low estrogen lev-
els, speciﬁcally estradiol and estrone in women who  smoke
compared with non-smokers.35 Nicotine interferes with the
estrogen binding globulin and accelerates the follicular atresia
process, anticipating the onset of menopause, besides aggra-
vating the mentioned symptoms.8
In the present study associations between physical activ-
ity and severity of menopausal symptoms were not observed,
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owever several studies demonstrate that regular physical
ctivity has a protective effect, reducing the occurrence of
ostmenopausal symptoms.8,15,36
In the multivariate analysis, a borderline p-value (p < 0.07)
as found for the association between WHR  ≥0.80 and preva-
ence of moderate to severe symptoms. In the study of Paolillo
t al., a statistically signiﬁcant association was observed
p < 0.05) between WHR  >0.80 and higher scores for somatic
nd urogenital symptoms.4
Regarding BMI, signiﬁcant statistical associations were not
bserved with severity of menopausal symptoms. Several
tudies have investigated this correlation, showing conﬂicting
esults. In 2005, De Lorenzi et al. observed no statisti-
ally signiﬁcant difference between obesity and severity of
enopausal symptoms.8 Another study in 2007 conﬁrmed
his ﬁnding.16 In 2010, Fernandez-Alonso using different
utoff points to diagnose obesity, demonstrated that obese
omen  presented 3.35 times more  chances to present
oderate to severe symptoms compared with non-obese
omen (p < 0.01).14 A recent Brazilian study demonstrated
hat obese women reported more  symptoms than non-
bese women. It was also particularly observed that obese
omen reported more  severe vasomotor symptoms, which are
ypoestrogenism-related symptoms.18 Theoretically, women
ith higher BMI, had less severe vasomotor symptoms due
o the increased estrogen levels via peripheral conversion of
ndrostenedione.18 Nevertheless, some studies have shown
hat actions of adipose tissue, such as thermal isolation,
roduce higher body temperatures and result in increased
asomotor symptoms, being a possible explanation for asso-
iation between severe climacteric symptoms and higher
MI.14,18
The obtained results evidenced a high prevalence of
omen with some type of postmenopausal symptom and
ore than half with moderate to severe symptoms. Our ﬁnd-
ngs suggest that age constituted a protection factor, having
ithin 6–10 years of menopause, being smoker and unem-
loyed or housewife are factors associated with severity
f menopausal symptoms. Associations between severity of
ymptoms and physical activity were not observed, indicating
 possible limitation in the measurement of this variable in the
resent study, as evaluation of practice of physical exercises
ould be necessary.
The questionnaire used to evaluate the menopausal symp-
oms was not submitted to a formal validation process in
razil, representing another limitation of the study. In addi-
ion, due to the cross-sectional study design, it was difﬁcult
o establish causal relations. However, this questionnaire was
hosen because of its broad clinical applicability and for being
he questionnaire recommended by the Brazilian Federation of
ynecology and Obstetrics (FEBRASGO), in addition to already
e used in the clinic for routine medical records. Another lim-
tation of the study, refers to the recruitment of patients have
een just the gynecology outpatient clinic, as this article was
art of the results of the dissertation of an author, with the
earch ﬁeld the gynecology outpatient clinic.Further studies are of great importance to verify pos-
ible predicting factors of menopausal symptoms, in order
o allow the increase of preventive actions and therapeutic
pproaches, both medical or not, to provide women with the
1;3  0(2):70–76 75
best quality of life in such important phase which is the post
menopause and the entire climacteric period.
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